VOYA Investment Management
DFTX

VOYA Investment Management’s Definium Therapeutics DFTX Stock Holding History

VOYA Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
95,166
+78,782
+481% +$1.95M ﹤0.01% 913
2026
Q1 		$310K Buy
16,384
+392
+2% +$6.65K ﹤0.01% 1936
2025
Q4 		$214K Buy
15,992
+1,710
+12% +$21.2K ﹤0.01% 2121
2025
Q3 		$168K Sell
14,282
-6,979
-33% -$65.1K ﹤0.01% 2218
2025
Q2 		$138K Buy
21,261
+146
+0.7% +$960 ﹤0.01% 2411
2025
Q1 		$124K Sell
21,115
-2,551
-11% -$18.3K ﹤0.01% 2386
2024
Q4 		$165K Sell
23,666
-637
-3% -$4.38K ﹤0.01% 2446
2024
Q3 		$138K Buy
24,303
+95
+0.4% +$661 ﹤0.01% 2584
2024
Q2 		$175K Buy
+24,208
New +$212K ﹤0.01% 2510
2022
Q1 		– Sell
-8,971
Closed -$186K – 2719
2021
Q4 		$186K Buy
8,971
+12
+0.1% +$383 ﹤0.01% 2538
2021
Q3 		$313K Buy
8,959
+527
+6% +$22.8K ﹤0.01% 2321
2021
Q2 		$436K Buy
+8,432
New +$443K ﹤0.01% 2172

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

VOYA Investment Management's DFTX Position: Q2 2026 in Review

VOYA Investment Management increased its Definium Therapeutics (DFTX) stake by 481% in Q2 2026, buying an estimated $1.95M and bringing the position to 95,166 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #913.

VOYA Investment Management first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • VOYA Investment Management held 95,166 shares of Definium Therapeutics worth $4.48M as of Q2 2026.
  • VOYA Investment Management bought 78,782 Definium Therapeutics shares in Q2 2026, an estimated $1.95M.
  • Definium Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #913 holding.
  • VOYA Investment Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.